2m 2m 2m 2m 2m 2m 2m
Vistagen Thera (VTGN)
NASDAQ
$0.24-$0.001 (-0.42%)
Price as of Sep 11, 2026 6:28 PM EDT- $10.5MMarket Cap
- -93.01%1-Year Change
- BiotechnologyIndustry
Vistagen Thera (VTGN)
$0.24-$0.001 (-0.42%)
VTGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.24 | ||
Change | -$0.002 (-0.84%) | ||
Open | $0.24 | ||
High | $0.24 | ||
Low | $0.23 | ||
Previous Close | $0.24 | ||
Volume | 309,992 | ||
30-Day Average Volume | 618,289 | ||
1-Week Change | -2.39% | ||
1-Month Change | -11.93% | ||
1-Year Change | -93.01% | ||
3-Year Change | -96.44% | ||
5-Year Change | -99.74% | ||
Fundamentals | |||
Shares Outstanding | 44.4M | ||
Total Assets | $35.7M | ||
Market Cap | $10.5M | ||
Enterprise Value | -$6.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$13.0M | ||
Free Cash Flow | -$14.7M | ||
EBIT | -$13.0M | ||
EBITDA | -$13.0M | ||
Net Working Capital | $23.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -4 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 06/07/2023 | ||
Earnings & Revenue